Our Resources | Association for Accessible Medicines

In the News - AAM CEO Dan Leonard shares the industry's 2021 outlook with Chain Drug Review.

USA flag with generic medicines

Jan 21, 2021 | Rachel Schwartz

AAM Statement on Biden’s Executive Orders to Strengthen America’s COVID Response

Friendly pharmacist hands a paper bag to young female customer at the checkout counter

Jan 15, 2021 | Rachel Schwartz

AAM and Biosimilars Council Statement on CMS Decision to Update Part D Program

Jan 6, 2021 | Dan Leonard

2021 Generics and Biosimilars Outlook

Jean Hoffman

Jan 4, 2021 | Bob Billings

Thank you, Jean Hoffman

Video

Dec 17, 2020 | Erica Klinger

Helen's Story — She Knows She Can Rely on Biosimilars

Helen, 41, from Florida, knows she can rely on biosimilars for her non-Hodgkin lymphoma

Dec 17, 2020 | Erica Klinger

Helen Knows She Can Rely on Biosimilars

GRx+Biosims 2020 Recap

Dec 17, 2020 | Erica Klinger

GRx+Biosims Recap: A Virtual Success

Oppose the Blocking Act #Preserve180

Dec 14, 2020 | Dan Leonard

Congress Should Preserve—Not Limit—Patient Access to New Generics

Katherine Tai

Dec 10, 2020 | Rachel Schwartz

AAM Statement on President-elect Biden Naming Katherine Tai as U.S. Trade Representative

Attorney General Xavier Becerra speaking with attendees at the 2019 California Democratic Party State Convention at the George R. Moscone Convention Center in San Francisco, California.

Dec 7, 2020 | Rachel Schwartz

AAM Statement on President-elect Biden Naming Xavier Becerra as Secretary of Health and Human Services

Catholic Medical Mission Board (CMMB)

Dec 4, 2020 | Jewel Smith

A World of Difference: Associate Member CMMB’s Global Health Mission

AAM Amicus Brief

Dec 2, 2020 | Jeff Francer

U.S. v. Arthrex